Type 2 Diabetes Treated With Insulin

Metabolic Diseases
1
Pipeline Programs
5
Companies
9
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Novo Nordisk
Novo NordiskBAGSVAERD DENMARK, Denmark
3 programs
1
Insulin glarginePhase 31 trial
Intelligent telemonitoringN/A1 trial
TelemonitoringN/A1 trial
Active Trials
NCT06185296Recruiting51Est. Sep 2026
NCT04981808Completed331Est. Nov 2023
NCT04460326Completed137Est. May 2023
Diabeloop
DiabeloopFrance - Grenoble
1 program
ActimetryN/A1 trial
Active Trials
NCT04522882CompletedEst. Dec 2020
Abbott
AbbottABBOTT PARK, IL
1 program
FreeStyle Libre 2 Flash Glucose Monitoring SystemN/A4 trials
Active Trials
NCT06268808Completed90Est. Sep 2025
NCT06268821Terminated11Est. Jul 2024
NCT05168306Terminated43Est. Jul 2023
+1 more trials
Glooko
GlookoCA - Palo Alto
1 program
TelemonitoringN/A
Pacific Science
Pacific ScienceCA - Torrance
1 program
Use of novel insulin injection portN/A1 trial
Active Trials
NCT05185518UnknownEst. Feb 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Novo NordiskInsulin glargine
Novo NordiskIntelligent telemonitoring
Pacific ScienceUse of novel insulin injection port
AbbottFreeStyle Libre 2 Flash Glucose Monitoring System
AbbottFreeStyle Libre 2 Flash Glucose Monitoring System
AbbottFreeStyle Libre 2 Flash Glucose Monitoring System
Novo NordiskTelemonitoring
AbbottFreeStyle Libre 2 Flash Glucose Monitoring System
DiabeloopActimetry

Clinical Trials (9)

Total enrollment: 725 patients across 9 trials

NCT04460326Novo NordiskInsulin glargine

Novolog vs. Fiasp Insulin in Non-critically Ill Hospitalized Patients With Type 2 Diabetes Mellitus

Start: Dec 2020Est. completion: May 2023137 patients
Phase 3Completed
NCT06185296Novo NordiskIntelligent telemonitoring

The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy

Start: Nov 2025Est. completion: Sep 202651 patients
N/ARecruiting
NCT05185518Pacific ScienceUse of novel insulin injection port

Assessment of an Integrated Continuous Glucose Monitor and Insulin Injection Port in Type 2 Diabetes

Start: Sep 2025Est. completion: Feb 2026
N/AUnknown
NCT06268808AbbottFreeStyle Libre 2 Flash Glucose Monitoring System

Initiation of Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin, in Italy

Start: Jul 2024Est. completion: Sep 202590 patients
N/ACompleted
NCT06268821AbbottFreeStyle Libre 2 Flash Glucose Monitoring System

Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated With Basal Insulin in Finland

Start: Apr 2024Est. completion: Jul 202411 patients
N/ATerminated
NCT05168306AbbottFreeStyle Libre 2 Flash Glucose Monitoring System

T2 FSL2 Weight Loss

Start: Dec 2021Est. completion: Jul 202343 patients
N/ATerminated
NCT04981808Novo NordiskTelemonitoring

Diabetes teleMonitoring of Patients in Insulin Therapy

Start: Aug 2021Est. completion: Nov 2023331 patients
N/ACompleted
NCT04577976AbbottFreeStyle Libre 2 Flash Glucose Monitoring System

FreeStyle Libre 2 Flash Glucose Monitoring System Control Phase Study for Pediatric Patients - BG

Start: Sep 2020Est. completion: Jul 202262 patients
N/ATerminated
NCT04522882DiabeloopActimetry

Clinical Data Collection for the Closed Loop Development for the Type 2 Diabetes Treatment - DT2_1

Start: Sep 2020Est. completion: Dec 2020
N/ACompleted

Related Jobs in Metabolic Diseases

Manager, Patient Safety and Pharmacovigilance Operations

Kailera Therapeutics
Waltham, Massachusetts
8h ago

Senior Medical Science Liaison - Obesity - Northern CA, Central CA, NV

Amgen
California - San Francisco, US
Yesterday

(Sr) Scientist Analytical Chemistry – Mass Spectrometry (Temporary role 3 years)

Johnson & Johnson
Beerse, Antwerp, Belgium
2d ago

Computational Chemist

Topos Bio
San Francisco Office
2d ago

Associate Director, Legal Operations & Contracts Management

Kailera Therapeutics
Massachusetts
4d ago
From $155K/yr

Application & Integration Architect

Roche
Indianapolis
5d ago
$106K - $196K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials targeting 725 patients
5 companies competing in this space

Related Indications

Diabetes(737)Diabetes Mellitus, Type 2(485)Obesity(246)Type 2 Diabetes(207)Type 2 Diabetes Mellitus(190)Diabetes Mellitus(127)Diabetes Mellitus, Type 1(95)Type 1 Diabetes Mellitus(51)Type 1 Diabetes(50)Dyslipidemia(45)